Harold Robert Meyer
The ADD Resource Center · · Published: October 2, 2026
For HCPs only
This article has not been medically reviewed. It is written for qualified healthcare professionals as a starting point for further research and should not be acted on before you consult the primary sources and apply your own clinical judgment.
When a patient has both conditions, common practice puts mood stabilization ahead of ADHD medication. The evidence explains why, and shows where the rule is softening.
A patient arrives with a long history of distractibility, restlessness, and mood swings, and the chart already carries an ADHD diagnosis. Or the chart says bipolar disorder, and the patient describes attention problems that began in grade school. Either way, you are working where two conditions overlap and are often mistaken for each other. Bipolar disorder can go unrecognized for years, with many patients not accurately diagnosed until up to 10 years after onset, and the CANMAT/ISBD guideline lists ADHD among the conditions whose symptoms overlap with mania (Yatham et al., 2018 · Free full text (PMC)).
Key Takeaway
Treating the mood disorder first and adding ADHD medication once mood is stable is common practice, and the evidence supports it as a strong default. Newer data on methylphenidate suggest it is a default, not an absolute rule.
Key Findings
- About 8% of adults with ADHD also have bipolar disorder, and about 17% of adults with bipolar disorder also have ADHD (Schiweck et al., 2021).
- Bipolar disorder begins roughly 4 years earlier when ADHD is also present (Schiweck et al., 2021).
- In a Swedish registry of 2,307 adults with bipolar disorder, methylphenidate without a mood stabilizer carried a hazard ratio of 6.7 for mania, versus 0.6 with one (Viktorin et al., 2017 · Free full text (PMC)).
- Comorbid ADHD in bipolar disorder goes with more mood episodes and 1.83 times the odds of a suicide attempt (Bartoli et al., 2023).
Why the Two Diagnoses Get Confused
Distractibility, restlessness, talkativeness, and impulsivity appear in both conditions, so a snapshot of symptoms can mislead. Course is the better guide. ADHD is chronic and non-episodic. Bipolar disorder arrives in distinct episodes of mania or hypomania and depression.
In a study of 60 women, ADHD interview measures and self-rated ADHD symptoms separated the two groups best, while scores for emotional lability and depression were raised in both. Bipolar-specific items worked better with a retrospective time frame (Kitsune et al., 2016).
Two cautions apply. Childhood onset is a strong clue for ADHD but not an absolute rule, because cohort studies reviewed by Katzman et al. (2017) found a substantial share of adults with ADHD had no childhood history of it. And a first manic episode after age 50 should prompt a search for an organic cause (Yatham et al., 2018).
Why Mood Comes First
Katzman and colleagues · Free full text (PMC) report that guidelines generally recommend treating the most impairing condition first, and that some clinicians advocate long-acting stimulants in bipolar disorder once mood has been stabilized. A brief clinical review reaches the same place for adults: stabilize the bipolar symptoms first, then introduce ADHD medication carefully while watching for mood episodes (Girard & Joober, 2017 · Free full text (PMC)).
What the Stimulant Data Show
The strongest caution comes from the Swedish registry. Methylphenidate given without a mood stabilizer was followed by a higher rate of mania, while methylphenidate given with one was not (Viktorin et al., 2017). A later Danish study of 1,043 patients found no increased risk of mania after methylphenidate was started (Jefsen et al., 2023).
Both studies are observational, and both concern methylphenidate, so they say little about amphetamine. Read together, they support mood stabilization first as a strong default and argue against treating “never” as a fixed rule.
What Is at Stake
Comorbid ADHD marks a harder course of bipolar disorder. A meta-analysis found earlier onset, more mood episodes, and higher odds of attempted suicide (Bartoli et al., 2023).
The Next Step
At your next intake, ask about past hypomania in every patient with ADHD, and about childhood inattention and hyperactivity in every patient with bipolar disorder. Chart mood and attention over several weeks so episodes become visible, and agree with the prescriber on who leads when both conditions are active. If mood is unstable, stabilize it first, then revisit ADHD treatment. Our companion pieces below cover the patient-facing side of the overlap.
Synopsis
Clinician-facing summary of how ADHD and bipolar disorder co-occur, how to tell them apart by course, and why mood stabilization usually precedes ADHD medication. Reviews the Swedish and Danish methylphenidate registry findings, and notes that amphetamine data are thin.
Topic: Medication (primary); Research (secondary)
Audience: Clinicians and prescribers
Keywords: ADHD and bipolar disorder, mood stabilizer first, stimulants and mania, comorbid ADHD, differential diagnosis
Bibliography
Bartoli, F., Callovini, T., Cavaleri, D., Cioni, R. M., Bachi, B., Calabrese, A., Moretti, F., Canestro, A., Morreale, M., Nasti, C., Palpella, D., Piacenti, S., Nacinovich, R., Riboldi, I., Crocamo, C., & Carrà, G. (2023). Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis. Australian & New Zealand Journal of Psychiatry, 57(1), 34–48. https://doi.org/10.1177/00048674221106669
Girard, R., & Joober, R. (2017). Treatment of ADHD in patients with bipolar disorder. Journal of Psychiatry & Neuroscience, 42(6), E11–E12. https://doi.org/10.1503/jpn.170097 · Free full text (PMC)
Jefsen, O. H., Østergaard, S. D., & Rohde, C. (2023). Risk of mania after methylphenidate in patients with bipolar disorder. Journal of Clinical Psychopharmacology, 43(1), 28–34. https://doi.org/10.1097/JCP.0000000000001631
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017). Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach. BMC Psychiatry, 17, Article 302. https://doi.org/10.1186/s12888-017-1463-3 · Free full text (PMC)
Kitsune, G. L., Kuntsi, J., Costello, H., Frangou, S., Hosang, G. M., McLoughlin, G., & Asherson, P. (2016). Delineating ADHD and bipolar disorder: A comparison of clinical profiles in adult women. Journal of Affective Disorders, 192, 125–133. https://doi.org/10.1016/j.jad.2015.12.024
Schiweck, C., Arteaga-Henriquez, G., Aichholzer, M., Edwin Thanarajah, S., Vargas-Cáceres, S., Matura, S., Grimm, O., Haavik, J., Kittel-Schneider, S., Ramos-Quiroga, J. A., Faraone, S. V., & Reif, A. (2021). Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 124, 100–123. https://doi.org/10.1016/j.neubiorev.2021.01.017
Viktorin, A., Rydén, E., Thase, M. E., Chang, Z., Lundholm, C., D’Onofrio, B. M., Almqvist, C., Magnusson, P. K., Lichtenstein, P., Larsson, H., & Landén, M. (2017). The risk of treatment-emergent mania with methylphenidate in bipolar disorder. American Journal of Psychiatry, 174(4), 341–348. https://doi.org/10.1176/appi.ajp.2016.16040467 · Free full text (PMC)
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O’Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., … Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609 · Free full text (PMC)
Resources
From The ADD Resource Center:
- ADHD and Bipolar Disorder: Untangling the Overlap and Navigating Treatment
- ADHD or Bipolar Disorder – Which?
- What Do Bipolar and ADHD Have in Common? What Are the Differences?
- Bipolar Disorders
- The Overlap Between ADHD and Bipolar Disorder (audio presentation)
From other organizations:
- Bipolar Disorder – National Institute of Mental Health
- Co-occurrence of ADHD and Bipolar Disorder – Depression and Bipolar Support Alliance
- CANMAT/ISBD 2018 Guidelines for the Management of Patients with Bipolar Disorder (PDF)
About the Author
Harold Robert Meyer founded The ADD Resource Center in 1993 and has spent more than thirty years translating the lived experience of ADHD into practical guidance for individuals, families, and the clinicians and educators who work with them. He co-founded CHADD of New York in 1989 and went on to serve on CHADD National’s board and executive committee, including as Vice President of Finance. He was later elected to lead the Institute for the Advancement of ADHD Coaching. An author and international speaker, he has presented at the American Psychiatric Association Annual Meeting, CHADD national and local conferences, NYU Langone, Mount Sinai Medical Center, and Weill Cornell Medical College. Reach him at [email protected].
📚 Come back often — we add new evidence-based ADHD resources daily.
The ADD Resource Center
[email protected] · +1 (646) 205-8080 · 127 West 83rd St., Unit 133, New York, NY 10024-0840 USA
X · LinkedIn · Facebook · Substack · Newsletter
Please consider the environment before printing.
This article has not been medically reviewed. It is written for qualified healthcare professionals as a starting point for further research and should not be acted on before you consult the primary sources and apply your own clinical judgment. Some content and images may be created with AI assistance and may contain inaccuracies
Our content is educational and informational only – not medical, legal, financial, or other professional advice, nor a substitute for it, and should not be relied on as such. We strive for accuracy, but errors or omissions occur and information becomes outdated. Some content and images may be created with AI assistance and, though reviewed before publication, may contain inaccuracies. Our screening tools are not diagnostic instruments. Verify independently and consult a qualified professional before acting on anything here.
In the USA and Canada, call or text 988 anytime for free mental health and suicide prevention support, or call 911 if someone is in immediate danger. The ADD Resource Center is independent from these services and is not liable for any actions taken by you or by these services.
Under GDPR and CCPA, you may request access to, correction of, or deletion of your personal data at [email protected].
©2026 The ADD Resource Center · www.addrc.org